HomeNewsQuality / GMP

Piramal Pharma gets EIR from US FDA for Sellersville, USA facility

Piramal Pharma gets EIR from US FDA for Sellersville, USA facility

Piramal Pharma has announced that the US FDA has issued an Establishment Inspection Report (EIR) for the manufacturing facility located in Sellersville, USA. The inspection has now been successfully closed by the US FDA.

Read more on:
EIR Piramal Pharma US FDA
More news about: quality / gmp | Published by Sudeep Soparkar | April - 19 - 2023 | 876

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members